helospectin I
Names
[ CAS No. ]:
93438-37-0
[ Name ]:
helospectin I
Biological Activity
[Description]:
Helospectin I is a neuropeptide of the vasoactive intestinal peptide (VIP) family. Helospectin I has vasodilatory and antihypertensive activities, and decreases blood pressure. Helospectin I is originally isolated from the salivary gland venom of the lizard Heloderma suspectum[1][2].
[Related Catalog]:
[Target]
Vasoactive intestinal peptide (VIP)[1]
[In Vitro]
Helospectin I (suffusion at 0.1 nM, in bicarbonate buffer for 30 min) evokes significant, sustained and similar vasodilation in the intact hamster cheek pouch[1]. Helospectin I relaxes the Phenylephrine-contracted rat femoral arteries with pEC50 of 6.82[2]. Helospectin I (0.1 nM-1 μM) inhibits the binding of 125I-labeled VIP and 125I-secretin to dispersed chief cells[4].
[In Vivo]
Helospectin I (0.03-2 nmol/kg, 100 μL of infusion at the left jugular vein) reduces blood pressure in rats[2]. Helospectin I (0.1-0.8 nmol /kg, i.v.) increases plasma levels of glucagon in mice[3]. Animal Model: SD rats[2] Dosage: 0.03, 0.3, 1, 2 nM/kg Administration: 100 μL of infusion at the left jugular vein, followed by washing the catheter with 100 μL saline. Result: Reduced the blood pressure, but was less effective than vasoactive intestinal peptide (VIP) in the low dose range. Animal Model: Mice[3] Dosage: 0.1, 0.2, 0.4, 0.8 nM /kg Administration: Intravenous injection (i.v.) Result: Markedly stimulated glucagon secretion, and had no direct action on insulin secretion.
[References]
Chemical & Physical Properties
[ Molecular Formula ]:
C183H293N47O59
Related Compounds
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.